VYNT
|
$0.194
-8.51%
19K
|
Health Care and Social Assistan...
(0.0% 1d)
(0.0% 1m)
(-48.3% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(1671.02%
volume)
Earnings Calendar: 2023-03-29
Market Cap: $ 1,227,778
https://www.vyantbio.com
Sec
Filling
|
Patents
| n/a employees
(US) Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.
add to watch list
Paper trade
email alert is off